Mouse models of diffuse large B cell lymphoma

Mouse models of diffuse large B cell lymphoma

Diffuse large B cell lymphoma (DLBCL) is a genetically highly heterogeneous disease. Yet, to date, the vast majority of patients receive standardized frontline chemo-immune-therapy consisting of an anthracycline backbone. Using these regimens, approximately 65% of patients can be cured, whereas the...

Full description

Bibliographic Details
Main Authors: Areya Tabatabai, Aastha Arora, Svenja Höfmann, Maximilian Jauch, Bastian von Tresckow, Julia Hansen, Ruth Flümann, Ron D. Jachimowicz, Sebastian Klein, Hans Christian Reinhardt, Gero Knittel
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
diffuse large B cell lymphoma (DLBCL)
genetically engineered (GE) animals
lymphoma
animal models
mouse models
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1313371/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1313371/full

Similar Items